These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 11034767)

  • 1. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
    Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction.
    Daya S; Gunby J
    Hum Reprod; 1999 Sep; 14(9):2207-15. PubMed ID: 10469682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis.
    Ravhon A; Lavery S; Aurell R; Trew G; Margara R; Winston R
    Fertil Steril; 2001 May; 75(5):920-5. PubMed ID: 11334903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
    Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; van Der Veen F
    Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
    Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles.
    Yang C; Dong N; Li F; Ji Y; Pan Y; She H
    J Ovarian Res; 2022 Jun; 15(1):74. PubMed ID: 35729654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles.
    van Wely M; Kwan I; Burt AL; Thomas J; Vail A; Van der Veen F; Al-Inany HG
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD005354. PubMed ID: 21328276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Westergaard LW; Bossuyt PM; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003973. PubMed ID: 21328264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness, safety and cost of urinary follicle stimulating hormone in controlled ovarian stimulation in China: multi-center retrospective cohort study of 102 061 in vitro fertilization cycles].
    Zhu YM; Gao Y; Nai DH; Hu LL; Jin L; Zhong Y; Wu Z; Hao GM; Wu QF; Guan YC; Jiang H; Zhang CL; Liu ML; Wang XH; Teng XM; Duan JL; Li LR; Zhang Y; Ye H
    Zhonghua Fu Chan Ke Za Zhi; 2022 Jul; 57(7):510-518. PubMed ID: 35902785
    [No Abstract]   [Full Text] [Related]  

  • 19. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.